La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
1933 Industries Résultats passés
Passé contrôle des critères 0/6
1933 Industries has been growing earnings at an average annual rate of 10.1%, while the Pharmaceuticals industry saw earnings growing at 48.2% annually. Revenues have been growing at an average rate of 4% per year.
Informations clés
10.1%
Taux de croissance des bénéfices
26.2%
Taux de croissance du BPA
Pharmaceuticals Croissance de l'industrie | 23.1% |
Taux de croissance des recettes | 4.0% |
Rendement des fonds propres | n/a |
Marge nette | -49.5% |
Prochaine mise à jour des résultats | 28 Nov 2024 |
Mises à jour récentes des performances passées
Recent updates
Further Upside For 1933 Industries Inc. (CSE:TGIF) Shares Could Introduce Price Risks After 33% Bounce
Feb 221933 Industries Inc. (CSE:TGIF) Soars 33% But It's A Story Of Risk Vs Reward
Dec 22Is 1933 Industries (CSE:TGIF) Using Too Much Debt?
Aug 111933 Industries Inc.'s (CSE:TGIF) Popularity With Investors Is Under Threat From Overpricing
Jun 17Is 1933 Industries (CSE:TGIF) Weighed On By Its Debt Load?
Apr 10Does 1933 Industries (CSE:TGIF) Have A Healthy Balance Sheet?
Oct 15Is 1933 Industries (CSE:TGIF) Using Debt Sensibly?
Jun 30Does 1933 Industries (CSE:TGIF) Have A Healthy Balance Sheet?
Mar 17Auditors Have Doubts About 1933 Industries (CSE:TGIF)
Dec 02Is 1933 Industries (CSE:TGIF) A Risky Investment?
Oct 21Is 1933 Industries (CSE:TGIF) Using Too Much Debt?
Jul 08Ventilation des recettes et des dépenses
Comment 1933 Industries gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Apr 24 | 20 | -10 | 5 | 0 |
31 Jan 24 | 19 | -13 | 5 | 0 |
31 Oct 23 | 19 | -13 | 5 | 0 |
31 Jul 23 | 18 | -13 | 5 | 0 |
30 Apr 23 | 16 | -8 | 4 | 0 |
31 Jan 23 | 16 | -17 | 5 | 0 |
31 Oct 22 | 15 | -18 | 4 | 0 |
31 Jul 22 | 13 | -18 | 4 | 0 |
30 Apr 22 | 12 | -17 | 4 | 0 |
31 Jan 22 | 12 | -4 | 4 | 0 |
31 Oct 21 | 12 | -5 | 4 | 0 |
31 Jul 21 | 12 | -6 | 6 | 0 |
30 Apr 21 | 12 | -9 | 9 | 0 |
31 Jan 21 | 11 | -14 | 11 | 0 |
31 Oct 20 | 11 | -18 | 15 | 0 |
31 Jul 20 | 12 | -19 | 17 | 0 |
30 Apr 20 | 15 | -20 | 16 | 0 |
31 Jan 20 | 17 | -22 | 16 | 0 |
31 Oct 19 | 17 | -19 | 15 | 0 |
31 Jul 19 | 18 | -18 | 15 | 0 |
30 Apr 19 | 17 | -16 | 15 | 0 |
31 Jan 19 | 15 | -10 | 12 | 0 |
31 Oct 18 | 15 | -8 | 11 | 0 |
31 Jul 18 | 13 | -5 | 9 | 0 |
30 Apr 18 | 10 | -4 | 7 | 0 |
31 Jan 18 | 6 | -4 | 6 | 0 |
31 Oct 17 | 3 | -3 | 4 | 0 |
31 Jul 17 | 1 | -3 | 3 | 0 |
30 Apr 17 | 0 | -3 | 1 | 0 |
31 Jan 17 | 0 | -3 | 1 | 0 |
31 Oct 16 | 0 | -4 | 2 | 0 |
31 Jul 16 | 0 | -4 | 2 | 0 |
Des revenus de qualité: TGIF is currently unprofitable.
Augmentation de la marge bénéficiaire: TGIF is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: TGIF is unprofitable, but has reduced losses over the past 5 years at a rate of 10.1% per year.
Accélération de la croissance: Unable to compare TGIF's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: TGIF is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-19.4%).
Rendement des fonds propres
ROE élevé: TGIF's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.